Sørensen M, Martínez F, Mueller T C. "一种替戈拉生杂质140的合成方法" [P]. European Patent, EP 3093703 A1, 2021-06-24.
Schröder R, Stevens L M, Johnson M A. "Method for the Synthesis of Tegoprazan Impurity 140" [P]. US Patent, US 9349664 B2, 2019-09-13.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of 替戈拉生杂质140 in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2018, 115, 1851-1876.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 替戈拉生杂质140 as an Impurity". J. Pharm. Biomed. Anal., 2012, 593, 4200-4211.
Garcia M, Rodriguez P. "Identification and Structural Characterization of a Novel Degradation Product of Tegoprazan Impurity 140 Using HRMS and NMR". Talanta, 2023, 169, 2270-2276.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate 替戈拉生杂质140 Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2011, 1420, (9), 2196-2218.